Immunotherapies

Immunotherapies

Therapeutic antibodies like Herceptin and Rituxan rely on the effector function — ADCC, AD complement — for their efficacy. SeromYx can screen a panel of thousands antibodies to identify a more potent candidate than what exists. Screening to find a more potent candidate.
 

1. DISCOVERY 

What function or mix of function correlates with therapeutic efficacy of  immunotherapies including monoclonal therapeutic antibodies?

Case Study:  Discovery – Guiding monoclonal antibody selection and development

Case STudy

2. LEAD SELECTION

What product construct best delivers the desired mix of function?

Case Study:  Lead Selection

Case Study

3. ASSAY DEVELOPMENT, QUALIFICATION, VALIDATION 

Which assays need to be demonstrated to be statistically robust so that data from them can be included in regulatory filings?

Case Study:  Coming soon

4. CLINICAL EFFICACY TESTING

Tracking specified functions in clinical trial samples as a surrogate clinical endpoint.

Case Study:  Coming soon

5. MANUFACTURING SCALE-UP 

Does therapeutic product biophysical and functional quality stay the same during process development?

Case Study:  Manufacturing Scale Up

 

Case Study

Let's Talk - Contact us today to discuss your project.